GLP-1s and SGLT2s: The New Power Players in Diabetes Care By 2024, more Medicare patients with T2D are sticking with GLP-1 or SGLT2 therapies as their sole treatment, doubling since 2020
Mc Carthy DJ, Malhotra M, OMahony AM, Cryan JF, ODriscoll CM
May Prevent the Need for Surgery Surgery is typically for whenever youve exhausted all your options
This gives a clinician your medical history, current medications, and treatment goals
However, if new symptoms developsuch as persistent headaches, visual changes, chest discomfort, or shortness of breathblood pressure should be checked promptly
Semaglutide GLP-1 can improve your bodys response to insulin and help maintain stable blood sugar levels, reducing the risk of future health complications